Breaking News Instant updates and real-time market news.

VEEV

Veeva

$288.00 /

+0.78 (+0.27%)

10:55
10/29/20
10/29
10:55
10/29/20
10:55

Veeva to hold analyst and investor day

Analyst & Investor Day to be held on October 29 at 11 am. Webcast Link

  • 29

    Oct

VEEV Veeva
$288.00 /

+0.78 (+0.27%)

10/26/20 Raymond James
Veeva price target raised to $335 from $285 at Raymond James
10/13/20 UBS
Veeva initiated with a Sell at UBS
08/31/20 Morgan Stanley
Veeva price target raised to $323 from $253 at Morgan Stanley
08/28/20 FBN Securities
Veeva price target raised to $310 from $300 at FBN Securities

TODAY'S FREE FLY STORIES

Recommendations
Ra Medical Systems price target lowered to $7 from $12 at Piper Sandler » 17:58
11/29/20
11/29
17:58
11/29/20
17:58
RMED

Ra Medical Systems

$6.80 /

+0.06 (+0.89%)

Piper Sandler analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
RMED Ra Medical Systems
$6.80 /

+0.06 (+0.89%)

RMED Ra Medical Systems
$6.80 /

+0.06 (+0.89%)

07/31/20 Piper Sandler
Ra Medical Systems price target lowered to 50c from $1 at Piper Sandler
03/12/20 Piper Sandler
Ra Medical's new CEO appointment a positive step, says Piper
03/11/20 Cantor Fitzgerald
Ra Medical Systems price target lowered to $1.50 from $2 at Cantor Fitzgerald
01/21/20 Piper Sandler
Ra Medical Systems announcement a 'positive first step,' says Piper Sandler
Downgrade
Lightspeed downgraded to Neutral from Buy at BTIG » 17:57
11/29/20
11/29
17:57
11/29/20
17:57
LSPD

Lightspeed

$55.08 /

+3.96 (+7.75%)

BTIG analyst Mark Palmer…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
LSPD Lightspeed
$55.08 /

+3.96 (+7.75%)

LSPD Lightspeed
$55.08 /

+3.96 (+7.75%)

11/09/20 RBC Capital
Lightspeed price target raised to $56 from $47 at RBC Capital
11/06/20 CIBC
Lightspeed price target raised to C$67 from C$50 at CIBC
11/06/20 BMO Capital
Lightspeed price target raised to C$62 from C$50 at BMO Capital
11/06/20 Scotiabank
Lightspeed price target raised to C$56 from C$51 at Scotiabank
  • 11
    Sep
LSPD Lightspeed
$55.08 /

+3.96 (+7.75%)

LSPD Lightspeed
$55.08 /

+3.96 (+7.75%)

Hot Stocks
EverQuote announces sudden passing of co-founder, CEO Seth Birnbaum » 16:01
11/29/20
11/29
16:01
11/29/20
16:01
EVER

EverQuote

$40.99 /

+0.05 (+0.12%)

EverQuote issued the…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
EVER EverQuote
$40.99 /

+0.05 (+0.12%)

EVER EverQuote
$40.99 /

+0.05 (+0.12%)

11/03/20 Raymond James
EverQuote price target lowered to $51 from $63 at Raymond James
11/03/20 JPMorgan
EverQuote price target lowered to $54 from $60 at JPMorgan
11/03/20 Oppenheimer
EverQuote price target lowered to $55 from $65 at Oppenheimer
09/14/20 Canaccord
EverQuote meetings highlight continued momentum, says Canaccord
EVER EverQuote
$40.99 /

+0.05 (+0.12%)

EVER EverQuote
$40.99 /

+0.05 (+0.12%)

Periodicals
Tesla delayed Semi truck testing Musk's ability to scale up, WSJ says » 15:02
11/29/20
11/29
15:02
11/29/20
15:02
TSLA

Tesla

$585.32 /

+11.46 (+2.00%)

The Tesla semitrailer…

The Tesla semitrailer truck is part of a flurry of vehicle-production activity Elon Musk has planned for 2021, The Wall Street Journal's Heather Somerville reports. Those plans include a new electric pickup truck, factories in Berlin and Texas starting up, and higher output at the company's Shanghai plant. Tesla is aiming to produce at least 68% more vehicles across its inventory next year, Musk has suggested, from the 500,000 car deliveries the company targets in 2020, the author notes. The Semi due to customers starting next year will be a new challenge for the Silicon Valley electric-car maker, testing how far Tesla has come with battery improvements it teased in September, how far it can push its manufacturing capabilities and whether the company can break into a new industry where Musk's star power has less pull among buyers primarily concerned about price and practicality, the publication adds. Reference Link

ShowHide Related Items >><<
TSLA Tesla
$585.32 /

+11.46 (+2.00%)

TSLA Tesla
$585.32 /

+11.46 (+2.00%)

11/27/20 BofA
BofA positive on long-term share gains for NIO Inc. after hosting calls
11/18/20
Fly Intel: Top five analyst upgrades
11/18/20 Morgan Stanley
Morgan Stanley upgrades Tesla on 'profound model shift' to recurring sales
11/18/20 Morgan Stanley
Tesla upgraded to Overweight from Equal Weight at Morgan Stanley
TSLA Tesla
$585.32 /

+11.46 (+2.00%)

  • 14
    Feb
TSLA Tesla
$585.32 /

+11.46 (+2.00%)

TSLA Tesla
$585.32 /

+11.46 (+2.00%)

TSLA Tesla
$585.32 /

+11.46 (+2.00%)

Periodicals
HSBC considers exit from U.S. retail banking, FT reports » 15:02
11/29/20
11/29
15:02
11/29/20
15:02
HSBC

HSBC

$26.89 /

+0.13 (+0.49%)

HSBC is weighing up a…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
HSBC HSBC
$26.89 /

+0.13 (+0.49%)

HSBC HSBC
$26.89 /

+0.13 (+0.49%)

11/10/20 Exane BNP Paribas
HSBC upgraded to Neutral from Underperform at Exane BNP Paribas
10/28/20 UBS
HSBC price target raised to 330 GBp from 310 GBp at UBS
10/28/20 Deutsche Bank
HSBC price target raised to 305 GBp from 300 GBp at Deutsche Bank
10/06/20 UBS
HSBC price target lowered to 310 GBp from 410 GBp at UBS
HSBC HSBC
$26.89 /

+0.13 (+0.49%)

HSBC HSBC
$26.89 /

+0.13 (+0.49%)

HSBC HSBC
$26.89 /

+0.13 (+0.49%)

HSBC HSBC
$26.89 /

+0.13 (+0.49%)

Hot Stocks
Moderna announces amendment to COVID vaccine supply agreement with U.K. » 14:43
11/29/20
11/29
14:43
11/29/20
14:43
MRNA

Moderna

$128.00 /

+18.82 (+17.24%)

Moderna announced a…

Moderna announced a supply agreement with the U.K. government for an additional 2M doses of mRNA-1273, Moderna's vaccine candidate against COVID-19, to the United Kingdom beginning in March 2021. The U.K. government has now secured 7M doses of mRNA-1273. On November 16, Moderna announced that the independent, NIH-appointed Data Safety Monitoring Board for the Phase 3 study of mRNA-1273, its vaccine candidate against COVID-19, has informed Moderna that the trial has met the statistical criteria pre-specified in the study protocol for efficacy, with a vaccine efficacy of 94.5%. This study, known as the COVE study, enrolled more than 30,000 participants in the U.S. and is being conducted in collaboration with the National Institute of Allergy and Infectious Diseases, part of the National Institutes of Health, and the Biomedical Advanced Research and Development Authority, part of the Office of the Assistant Secretary for Preparedness and Response at the U.S. Department of Health and Human Services. On October 27, 2020, Moderna received confirmation that the Medicines and Healthcare products Regulatory Agency in the U.K. started the rolling review process of mRNA-1273. Moderna continues to scale up its global manufacturing to be able to deliver approximately 500M doses per year and possibly up to 1B doses per year, beginning in 2021.

ShowHide Related Items >><<
MRNA Moderna
$128.00 /

+18.82 (+17.24%)

MRNA Moderna
$128.00 /

+18.82 (+17.24%)

11/27/20 Argus
AstraZeneca's COVID vaccine faces high bar for FDA authorization, says Argus
11/25/20 Goldman Sachs
Moderna price target raised to $139 from $107 at Goldman Sachs
11/23/20
Fly Intel: Top five analyst initiations
11/23/20 Wells Fargo
Moderna initiated with an Equal Weight at Wells Fargo
MRNA Moderna
$128.00 /

+18.82 (+17.24%)

  • 19
    May
  • 12
    Feb
MRNA Moderna
$128.00 /

+18.82 (+17.24%)

MRNA Moderna
$128.00 /

+18.82 (+17.24%)

MRNA Moderna
$128.00 /

+18.82 (+17.24%)

Hot Stocks
Aegon to sell Central, Eastern European business to VIG » 14:35
11/29/20
11/29
14:35
11/29/20
14:35
AEG

Aegon

$3.63 /

-0.02 (-0.55%)

Aegon has agreed to sell…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
AEG Aegon
$3.63 /

-0.02 (-0.55%)

AEG Aegon
$3.63 /

-0.02 (-0.55%)

11/19/20 Morgan Stanley
Aegon price target raised to EUR 3.30 from EUR 2.80 at Morgan Stanley
10/01/20 JPMorgan
Aegon upgraded to Overweight from Neutral at JPMorgan
09/22/20 RBC Capital
Aegon price target lowered to EUR 2.50 from EUR 3 at RBC Capital
09/08/20 Barclays
Aegon price target lowered to EUR 2.00 from EUR 2.90 at Barclays
Hot Stocks
WaterMill Asset Management refutes Ziopharm Oncology's 'desperate' campaign » 14:29
11/29/20
11/29
14:29
11/29/20
14:29
ZIOP

Ziopharm

$2.90 /

-0.025 (-0.85%)

WaterMill Asset…

WaterMill Asset Management, which collectively with the other participants in its consent solicitation beneficially owns approximately 3.3% of the outstanding shares of Ziopharm Oncology, responded to "the low-road campaign that the incumbent Board of Directors has apparently initiated in order to smear Holger Weis and misrepresent his more than six-year tenure at DemeRx," the former said. WaterMill believes this "seemingly underhanded stunt" only reinforces the need for meaningful and urgent boardroom change. WaterMill added that, "It is important to highlight that the incumbent Board's desperate attack on Weis comes on the heels of Institutional Shareholder Services, a leading independent proxy voting advisory firm, recommending that Ziopharm shareholders vote for boardroom change on WaterMill's WHITE consent card. ISS supports the addition of two WaterMill nominees and the removal of two incumbents."

ShowHide Related Items >><<
ZIOP Ziopharm
$2.90 /

-0.025 (-0.85%)

ZIOP Ziopharm
$2.90 /

-0.025 (-0.85%)

07/10/20 Lake Street
Ziopharm took 'important step' with start of CAR-T study, says Lake Street
06/19/20 Jefferies
Ziopharm initiated with a Buy at Jefferies
05/11/20 H.C. Wainwright
Ziopharm price target lowered to $5.50 from $6.50 at H.C. Wainwright
03/04/20
Fly Intel: Top five analyst initiations
ZIOP Ziopharm
$2.90 /

-0.025 (-0.85%)

  • 05
    Feb
ZIOP Ziopharm
$2.90 /

-0.025 (-0.85%)

ZIOP Ziopharm
$2.90 /

-0.025 (-0.85%)

Hot Stocks
Dr. Reddy's to acquire select anti-allergy brands from Glenmark » 14:26
11/29/20
11/29
14:26
11/29/20
14:26
RDY

Dr. Reddy's

$65.48 /

+1.12 (+1.74%)

Dr. Reddy's…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
RDY Dr. Reddy's
$65.48 /

+1.12 (+1.74%)

RDY Dr. Reddy's
$65.48 /

+1.12 (+1.74%)

09/18/20 Investec
Dr. Reddy's upgraded to Hold from Sell at Investec
09/03/20 Oppenheimer
Opco 'more skeptical' on Amarin patent win after 20 minute court hearing
09/02/20 Goldman Sachs
Oral arguments incrementally negative for Amarin, says Goldman Sachs
08/10/20 Oppenheimer
Amarin Perform rating affirmed at Oppenheimer after FDA approves Vascepa generic
RDY Dr. Reddy's
$65.48 /

+1.12 (+1.74%)

Hot Stocks
Shopify announces record global Black Friday sales of $2.4B » 14:22
11/29/20
11/29
14:22
11/29/20
14:22
SHOP

Shopify

$1,036.90 /

+17.49 (+1.72%)

Shopify announced…

Shopify announced record-setting Black Friday sales of $2.4B from the independent and direct-to-consumer brands on the platform worldwide. On November 27, from the start of Black Friday in New Zealand through the end of Black Friday in California, Shopify-powered businesses saw a 75% increase in sales from Black Friday in 2019. In fact, by 8:00am EST, merchants on Shopify collectively had crossed $1B in sales.

ShowHide Related Items >><<
SHOP Shopify
$1,036.90 /

+17.49 (+1.72%)

SHOP Shopify
$1,036.90 /

+17.49 (+1.72%)

11/19/20
Fly Intel: Top five analyst upgrades
11/19/20 Jefferies
Shopify upgraded to Buy from Hold at Jefferies
11/18/20 Baird
Shopify multiple levers seen to drive sustained profits, says Baird
11/16/20 Stifel
BigCommerce initiated with a Buy at Stifel
SHOP Shopify
$1,036.90 /

+17.49 (+1.72%)

  • 16
    Sep
  • 08
    May
SHOP Shopify
$1,036.90 /

+17.49 (+1.72%)

SHOP Shopify
$1,036.90 /

+17.49 (+1.72%)

SHOP Shopify
$1,036.90 /

+17.49 (+1.72%)

Hot Stocks
Ziopharm comments on Institutional Shareholder Services' report » 14:20
11/29/20
11/29
14:20
11/29/20
14:20
ZIOP

Ziopharm

$2.90 /

-0.025 (-0.85%)

Ziopharm Oncology has…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
ZIOP Ziopharm
$2.90 /

-0.025 (-0.85%)

ZIOP Ziopharm
$2.90 /

-0.025 (-0.85%)

07/10/20 Lake Street
Ziopharm took 'important step' with start of CAR-T study, says Lake Street
06/19/20 Jefferies
Ziopharm initiated with a Buy at Jefferies
05/11/20 H.C. Wainwright
Ziopharm price target lowered to $5.50 from $6.50 at H.C. Wainwright
03/04/20
Fly Intel: Top five analyst initiations
ZIOP Ziopharm
$2.90 /

-0.025 (-0.85%)

  • 05
    Feb
ZIOP Ziopharm
$2.90 /

-0.025 (-0.85%)

ZIOP Ziopharm
$2.90 /

-0.025 (-0.85%)

Hot Stocks
Citizens Holding announces cash dividend of 24c » 14:11
11/29/20
11/29
14:11
11/29/20
14:11
CIZN

Citizens Holding

$20.37 /

-0.38 (-1.83%)

Citizens Holding…

Citizens Holding announced that its Board of Directors declared a cash dividend of 24c per share payable December 31, 2020, to shareholders of record as of December 17, 2020. "Today we are announcing our fourth quarter 2020 dividend of 24c per share," said Greg McKee, President and Chief Executive Officer. "This dividend will bring the total dividend for 2020 to $0.96 per share of common stock."

Hot Stocks
Cedar Realty Trust announces completion of 1-for-6.6 reverse stock split » 14:09
11/29/20
11/29
14:09
11/29/20
14:09
CDR

Cedar Realty Trust

$9.15 /

-50.8308 (-84.75%)

Cedar Realty Trust…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
CDR Cedar Realty Trust
$9.15 /

-50.8308 (-84.75%)

CDR Cedar Realty Trust
$9.15 /

-50.8308 (-84.75%)

11/10/20 Compass Point
Compass Point upgrades four retail REITs to Neutral after Pfizer 'game changer'
11/09/20 Compass Point
Cedar Realty Trust upgraded to Neutral from Sell at Compass Point
04/03/20 B. Riley Securities
Cedar Realty Trust price target lowered to $2 from $5 at B. Riley FBR
12/19/19 Baird
Baird raises view on Shopping Center REITs to Outperform, upgrades RPT Realty
CDR Cedar Realty Trust
$9.15 /

-50.8308 (-84.75%)

Conference/Events
IMV Inc. to host conference call » 12:54
11/29/20
11/29
12:54
11/29/20
12:54
IMV

IMV Inc.

$3.58 /

+0.13 (+3.77%)

Management holds a Key…

Management holds a Key Opinion Leader conference call on the ovarian cancer treatment landscape and data highlights from the Phase 2 Trial of a Novel T-Cell Therapy on December 3 at 8 am. Webcast Link

ShowHide Related Items >><<
IMV IMV Inc.
$3.58 /

+0.13 (+3.77%)

IMV IMV Inc.
$3.58 /

+0.13 (+3.77%)

07/21/20 Industrial Alliance
IMV Inc. initiated with a Buy at Industrial Alliance
07/14/20 Wells Fargo
IMV Inc. price target raised to $11 from $8.50 at Wells Fargo
05/18/20 Wells Fargo
IMV Inc. upgraded to Overweight on COVID-19 vaccine potential at Wells Fargo
05/18/20 Wells Fargo
IMV Inc. upgraded to Overweight from Equal Weight at Wells Fargo
IMV IMV Inc.
$3.58 /

+0.13 (+3.77%)

Conference/Events
Sasol to host business news update conference call » 12:45
11/29/20
11/29
12:45
11/29/20
12:45
SSL

Sasol

$8.51 /

-0.08 (-0.93%)

CEO Grobler and CFO…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
SSL Sasol
$8.51 /

-0.08 (-0.93%)

SSL Sasol
$8.51 /

-0.08 (-0.93%)

06/08/20 JPMorgan
Sasol upgraded to Overweight from Neutral at JPMorgan
03/20/20 Goldman Sachs
Sasol downgraded to Neutral from Buy at Goldman Sachs
03/12/20 JPMorgan
Sasol downgraded to Neutral from Overweight at JPMorgan
02/27/20 Renaissance Capital
Sasol upgraded to Hold from Sell at Renaissance Capital
Conference/Events
KemPharm to host business news update conference call » 12:44
11/29/20
11/29
12:44
11/29/20
12:44
KMPH

KemPharm

$0.21 /

+ (+0.00%)

Management holds a…

Management holds a conference call to discuss the market opportunity and commercialization strategy for KP415 on December 2 at 10 am. Webcast Link

ShowHide Related Items >><<
KMPH KemPharm
$0.21 /

+ (+0.00%)

KMPH KemPharm
$0.21 /

+ (+0.00%)

05/20/20 H.C. Wainwright
KemPharm price target lowered to $1.50 from $2.50 at H.C. Wainwright
Conference/Events
Blackbaud to host business news update conference call » 12:40
11/29/20
11/29
12:40
11/29/20
12:40
BLKB

Blackbaud

$55.62 /

-0.65 (-1.16%)

Management discusses…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
BLKB Blackbaud
$55.62 /

-0.65 (-1.16%)

BLKB Blackbaud
$55.62 /

-0.65 (-1.16%)

08/28/20
Fly Intel: Top five analyst initiations
08/27/20 Stephens
Blackbaud initiated with an Overweight at Stephens
08/27/20 Stephens
Blackbaud initiated with an Overweight at Stephens
04/20/20 Evercore ISI
Blackbaud upgraded to In Line from Underperform at Evercore ISI
BLKB Blackbaud
$55.62 /

-0.65 (-1.16%)

BLKB Blackbaud
$55.62 /

-0.65 (-1.16%)

BLKB Blackbaud
$55.62 /

-0.65 (-1.16%)

Conference/Events
Asbury Automotive to host business news update conference call » 12:35
11/29/20
11/29
12:35
11/29/20
12:35
ABG

Asbury Automotive

$118.00 /

-2.8 (-2.32%)

President & CEO Hult…

President & CEO Hult and CFO Guido hold a conference call to unveil Clicklane, a completely online, comprehensive retail tool which offers real-time data-driven trade-in value on December 2 at 10 am. Webcast Link

ShowHide Related Items >><<
ABG Asbury Automotive
$118.00 /

-2.8 (-2.32%)

ABG Asbury Automotive
$118.00 /

-2.8 (-2.32%)

10/19/20 Seaport Global
Asbury Automotive initiated with a Buy at Seaport Global
10/16/20 Truist
Asbury Automotive price target raised to $120 from $110 at Truist
07/29/20 Craig-Hallum
Asbury Automotive downgraded to Hold from Buy at Craig-Hallum
07/09/20 Truist
Asbury Automotive price target raised to $100 from $70 at SunTrust
ABG Asbury Automotive
$118.00 /

-2.8 (-2.32%)

Conference/Events
Honeywell participates in a conference call with JPMorgan » 12:30
11/29/20
11/29
12:30
11/29/20
12:30
HON

Honeywell

$209.60 /

+1.71 (+0.82%)

Senior Analyst Tusa holds…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
HON Honeywell
$209.60 /

+1.71 (+0.82%)

HON Honeywell
$209.60 /

+1.71 (+0.82%)

11/24/20 Baird
Honeywell price target raised to $221 from $167 at Baird
11/18/20
Fly Intel: Top five analyst downgrades
11/18/20 Jefferies
Jefferies sees Honeywell at 'peak valuation,' downgrades to Hold
11/18/20 Jefferies
Honeywell downgraded to Hold from Buy at Jefferies
HON Honeywell
$209.60 /

+1.71 (+0.82%)

HON Honeywell
$209.60 /

+1.71 (+0.82%)

HON Honeywell
$209.60 /

+1.71 (+0.82%)

HON Honeywell
$209.60 /

+1.71 (+0.82%)

On The Fly
Opening Day: Russian online retailer raises $990M in U.S. IPO » 09:00
11/29/20
11/29
09:00
11/29/20
09:00
HFEN

HF Enterprises

$5.54 /

-0.57 (-9.34%)

, OZON

Ozon

$40.00 /

+1.33 (+3.44%)

, VMAR

Vision Marine Technologies

$14.45 /

-0.05 (-0.34%)

, FRX

Forest Road Acquisition

$0.00 /

+ (+0.00%)

, SVSV

Spring Valley Acquisition

$0.00 /

+ (+0.00%)

, TINV

Tiga Acquisition

$0.00 /

+ (+0.00%)

, GNPK

Genesis Park Acquisition

$0.00 /

+ (+0.00%)

, AIRB

Airbnb

$0.00 /

+ (+0.00%)

, DASH

DoorDash

$0.00 /

+ (+0.00%)

, AFRM

Affirm

$0.00 /

+ (+0.00%)

, RBLX

Roblox

$0.00 /

+ (+0.00%)

, HOMS

Caliber Home Loans

$0.00 /

+ (+0.00%)

, SGTX

Sigilon Therapeutics

$0.00 /

+ (+0.00%)

, SPRQ

Spartan Acquisition Corp. II

$0.00 /

+ (+0.00%)

, APO

Apollo Global

$43.90 /

+0.02 (+0.05%)

, VCVC

10X Capital Venture Acquisition

$0.00 /

+ (+0.00%)

, PYPL

PayPal

$211.88 /

-2.54 (-1.18%)

, NRZ

New Residential

$9.62 /

-0.095 (-0.98%)

Ozon Holdings, a Russian…

ShowHide Related Items >><<
PYPL PayPal
$211.88 /

-2.54 (-1.18%)

NRZ New Residential
$9.62 /

-0.095 (-0.98%)

APO Apollo Global
$43.90 /

+0.02 (+0.05%)

AIRB Airbnb
$0.00 /

+ (+0.00%)

HFEN HF Enterprises
$5.54 /

-0.57 (-9.34%)

OZON Ozon
$40.00 /

+1.33 (+3.44%)

VMAR Vision Marine Technologies
$14.45 /

-0.05 (-0.34%)

FRX Forest Road Acquisition
$0.00 /

+ (+0.00%)

SVSV Spring Valley Acquisition
$0.00 /

+ (+0.00%)

TINV Tiga Acquisition
$0.00 /

+ (+0.00%)

GNPK Genesis Park Acquisition
$0.00 /

+ (+0.00%)

AIRB Airbnb
$0.00 /

+ (+0.00%)

DASH DoorDash
$0.00 /

+ (+0.00%)

07/08/20 Wedbush
Postmates stronger fit for Uber, less market share than GrubHub, says Wedbush
07/06/20 Wedbush
Uber's acquisition of Postmates 'a smart strategic move,' says Wedbush
AFRM Affirm
$0.00 /

+ (+0.00%)

RBLX Roblox
$0.00 /

+ (+0.00%)

HOMS Caliber Home Loans
$0.00 /

+ (+0.00%)

SGTX Sigilon Therapeutics
$0.00 /

+ (+0.00%)

SPRQ Spartan Acquisition Corp. II
$0.00 /

+ (+0.00%)

APO Apollo Global
$43.90 /

+0.02 (+0.05%)

11/06/20
Fly Intel: Top five analyst upgrades
11/06/20 Morgan Stanley
Morgan Stanley upgrades Apollo Global to Overweight following underperformance
11/06/20 Morgan Stanley
Apollo Global upgraded to Overweight from Equal Weight at Morgan Stanley
10/29/20 BMO Capital
Apollo Global upgraded to Outperform from Market Perform at BMO Capital
VCVC 10X Capital Venture Acquisition
$0.00 /

+ (+0.00%)

PYPL PayPal
$211.88 /

-2.54 (-1.18%)

11/19/20 Morgan Stanley
Growth of Square's Cash App may be impacted by needed fixes, says Morgan Stanley
11/19/20 Keefe Bruyette
Too early to know if new Google Pay is PayPal, Square threat, says KBW
11/10/20 Mizuho
PayPal price target lowered to $270 from $290 at Mizuho
11/05/20 DZ Bank
PayPal upgraded to Buy from Hold at DZ Bank
NRZ New Residential
$9.62 /

-0.095 (-0.98%)

11/24/20 B. Riley Securities
New Residential price target raised to $11.50 from $9.50 at B. Riley Securities
11/23/20 BTIG
New Residential assumed with a Buy at BTIG
11/06/20 Wolfe Research
New Residential initiated with an Outperform at Wolfe Research
09/24/20 B. Riley Securities
New Residential shares offer 35% total return potential, says B. Riley FBR
PYPL PayPal
$211.88 /

-2.54 (-1.18%)

NRZ New Residential
$9.62 /

-0.095 (-0.98%)

APO Apollo Global
$43.90 /

+0.02 (+0.05%)

  • 24
    Nov
  • 24
    Nov
  • 24
    Nov
  • 29
    Oct
PYPL PayPal
$211.88 /

-2.54 (-1.18%)

DASH DoorDash
$0.00 /

+ (+0.00%)

APO Apollo Global
$43.90 /

+0.02 (+0.05%)

AIRB Airbnb
$0.00 /

+ (+0.00%)

PYPL PayPal
$211.88 /

-2.54 (-1.18%)

NRZ New Residential
$9.62 /

-0.095 (-0.98%)

HOMS Caliber Home Loans
$0.00 /

+ (+0.00%)

DASH DoorDash
$0.00 /

+ (+0.00%)

APO Apollo Global
$43.90 /

+0.02 (+0.05%)

AIRB Airbnb
$0.00 /

+ (+0.00%)

PYPL PayPal
$211.88 /

-2.54 (-1.18%)

NRZ New Residential
$9.62 /

-0.095 (-0.98%)

APO Apollo Global
$43.90 /

+0.02 (+0.05%)

Periodicals
Supercuts owner Regis stock a post-COVID play, Barron's says » 10:10
11/28/20
11/28
10:10
11/28/20
10:10
RGS

Regis

$8.43 /

-0.19 (-2.20%)

One company that is…

One company that is poised to meet pent-up demand next year and beyond is Regis, an owner and franchiser of about 6,700 barbershops and salons in the U.S., the U.K., and Canada, Nicholas Jasinski writes in this week's edition of Barron's. There is no other publicly traded company in this highly fragmented market, and many small, independent salons and barbershops won't be able to survive the pandemic, the author notes, adding that Regis stands a good chance of being able to grow its market share, currently less than 10% in North America. Reference Link

ShowHide Related Items >><<
RGS Regis
$8.43 /

-0.19 (-2.20%)

RGS Regis
$8.43 /

-0.19 (-2.20%)

10/30/20 B. Riley Securities
Regis price target raised to $160 from $155 at B. Riley Securities
10/22/20 Loop Capital
Regis downgraded to Hold from Buy at Loop Capital
10/22/20 Loop Capital
Regis downgraded to Hold from Buy at Loop Capital
06/19/20 Loop Capital
Regis price target lowered to $15 from $21 at Loop Capital
RGS Regis
$8.43 /

-0.19 (-2.20%)

RGS Regis
$8.43 /

-0.19 (-2.20%)

Periodicals
Apple's new MacBooks delight critics, investors should care too, Barron's says » 10:03
11/28/20
11/28
10:03
11/28/20
10:03
AAPL

Apple

$116.45 /

+0.42 (+0.36%)

, INTC

Intel

$47.56 /

+0.5 (+1.06%)

Critics have been raving…

Critics have been raving about Apple's (AAPL) MacBook Air, MacBook Pro and Mac mini, which are all powered by Apple's new M1 chip, Alex Eule writes in this week's edition of Barron's. The reviews featured benchmarking scores that showed the base-level MacBook outperforming some of the most expensive Macs, which still use chips from Intel (INTC), the author adds. Apple consumers are happy again and investors shouldn't tune out Mac developments, Eule contends. Reference Link

ShowHide Related Items >><<
INTC Intel
$47.56 /

+0.5 (+1.06%)

AAPL Apple
$116.45 /

+0.42 (+0.36%)

AAPL Apple
$116.45 /

+0.42 (+0.36%)

11/25/20 Rosenblatt
Apple taking RF front-end in-house 'highly unlikely,' says Rosenblatt
11/25/20
Survey shows Apple demand outlook better than expected, says TF International
11/24/20 Credit Suisse
Apple iPhone 12 mini quickly reaches supply/demand balance, says Credit Suisse
11/23/20 Credit Suisse
iPhone 12 Pro/Pro Max extend, mini approaches equilibrium, says Credit Suisse
INTC Intel
$47.56 /

+0.5 (+1.06%)

11/23/20 Mizuho
Micron price target raised to $70 from $56 at Mizuho
11/13/20 Morgan Stanley
Few weeks delay of Ice Lake shouldn't be major Intel issue, says Morgan Stanley
11/13/20 Mizuho
Intel checks show Ice Lake delay not as bad as feared, says Mizuho
11/11/20 Credit Suisse
Credit Suisse likes move to Apple silicon on Mac, unified product portfolio
INTC Intel
$47.56 /

+0.5 (+1.06%)

AAPL Apple
$116.45 /

+0.42 (+0.36%)

INTC Intel
$47.56 /

+0.5 (+1.06%)

AAPL Apple
$116.45 /

+0.42 (+0.36%)

INTC Intel
$47.56 /

+0.5 (+1.06%)

AAPL Apple
$116.45 /

+0.42 (+0.36%)

INTC Intel
$47.56 /

+0.5 (+1.06%)

AAPL Apple
$116.45 /

+0.42 (+0.36%)

Periodicals
Decking making pandemic bearable, good news for Azek, Barron's says » 09:18
11/28/20
11/28
09:18
11/28/20
09:18
AZEK

Azek

$34.33 /

-0.11 (-0.32%)

, TREX

Trex Company

$74.63 /

+1.11 (+1.51%)

For many people, decking…

For many people, decking has made the pandemic bearable, which has been a boon for decking supplier Azek (AZEK), Leslie Norton writes in this week's edition of Barron's. Azek and rival Trex (TREX) are No. 2 and No. 1, respectively, in composite wood decking. Sales for each company is expected to be just shy of $1B in 2021, but more than a third of Aztek's total comes from trim, shingles, and other products, the author notes, adding that the business is a source of cheap raw material for decking, through recycling of old trim. As a result, Aztek's profit margins are poised to expand briskly, he contends. Azek is also a sustainability play, as its major raw material is recycled products, much of which is scrap that Azek gets from customers, the publication says. Reference Link

ShowHide Related Items >><<
TREX Trex Company
$74.63 /

+1.11 (+1.51%)

AZEK Azek
$34.33 /

-0.11 (-0.32%)

11/12/20 BofA
Azek downgraded to Underperform from Neutral at BofA
10/13/20 Stifel
Azek resumed with a Buy at Stifel
09/30/20 Goldman Sachs
Azek upgraded to Conviction Buy from Neutral at Goldman Sachs
08/20/20 Barclays
Azek price target raised to $44 from $42 at Barclays
TREX Trex Company
$74.63 /

+1.11 (+1.51%)

11/05/20 Exane BNP Paribas
Trex Company upgraded to Neutral from Underperform at Exane BNP Paribas
11/03/20 DA Davidson
Trex Company price target raised to $75 from $65 at DA Davidson
11/03/20 Deutsche Bank
Trex Company price target raised to $75 from $72 at Deutsche Bank
TREX Trex Company
$74.63 /

+1.11 (+1.51%)

AZEK Azek
$34.33 /

-0.11 (-0.32%)

  • 11
    Sep
  • 12
    Jun
TREX Trex Company
$74.63 /

+1.11 (+1.51%)

AZEK Azek
$34.33 /

-0.11 (-0.32%)

AZEK Azek
$34.33 /

-0.11 (-0.32%)

Periodicals
Ford can be fixed, stock could double, Barron's says » 09:09
11/28/20
11/28
09:09
11/28/20
09:09
F

Ford

$9.10 /

+0.015 (+0.17%)

Ford is the fifth-largest…

Ford is the fifth-largest auto maker in the world based on the number of vehicles sold last year, but it barely cracks the top 15 in the stock value, which says everything about how Ford is viewed today - and the potential opportunity for investors, Al Root writes in this week's edition of Barron's. Despite its recent woes, Ford is still massive, annually selling about $150B worth of cars and trucks, and Better capital allocation and sharing platforms could help the U.S. car maker bolster its profits, the author notes. The opportunity for improvement is enormous, the publication adds. Reference Link

ShowHide Related Items >><<
F Ford
$9.10 /

+0.015 (+0.17%)

F Ford
$9.10 /

+0.015 (+0.17%)

11/25/20
Fly Intel: Top five analyst downgrades
11/25/20 Morgan Stanley
Morgan Stanley downgrades Ford to Equal Weight with EV strategy not fully clear
11/25/20 Morgan Stanley
Ford downgraded to Equal Weight from Overweight at Morgan Stanley
11/20/20 Needham
Ford launch an 'interesting response' to auto retailing shift, says Needham
F Ford
$9.10 /

+0.015 (+0.17%)

F Ford
$9.10 /

+0.015 (+0.17%)

F Ford
$9.10 /

+0.015 (+0.17%)

F Ford
$9.10 /

+0.015 (+0.17%)

On The Fly
Week in review: How Trump's policies moved stocks » 08:25
11/28/20
11/28
08:25
11/28/20
08:25
CGC

Canopy Growth

$28.98 /

+2.13 (+7.93%)

, ACB

Aurora Cannabis

$10.63 /

+1.92 (+22.04%)

, TLRY

Tilray

$8.69 /

+1.2 (+16.02%)

, CURLF

Curaleaf

$0.00 /

+ (+0.00%)

, GM

General Motors

$45.02 /

-0.46 (-1.01%)

Catch up on the top…

ShowHide Related Items >><<
TLRY Tilray
$8.69 /

+1.2 (+16.02%)

GM General Motors
$45.02 /

-0.46 (-1.01%)

CURLF Curaleaf
$0.00 /

+ (+0.00%)

CGC Canopy Growth
$28.98 /

+2.13 (+7.93%)

ACB Aurora Cannabis
$10.63 /

+1.92 (+22.04%)

CGC Canopy Growth
$28.98 /

+2.13 (+7.93%)

11/16/20 Jefferies
Canopy Growth price target raised to $21.10 from $16 at Jefferies
11/11/20 CIBC
Canopy Growth price target raised to C$32 from C$25 at CIBC
11/10/20 Canaccord
Canopy Growth price target raised to C$25 from C$22 at Canaccord
08/31/20 Roth Capital
Roth Capital believes MORE Act will not pass in 2020
ACB Aurora Cannabis
$10.63 /

+1.92 (+22.04%)

11/17/20 GLJ Research
With $0 target, GLJ says short Aurora Cannabis on recent rally
11/16/20
Fly Intel: Top five analyst downgrades
11/16/20 Jefferies
Jefferies cuts Aurora Cannabis to Underperform after 'unjustified' re-rating
11/16/20 Jefferies
Aurora Cannabis downgraded to Underperform from Hold at Jefferies
TLRY Tilray
$8.69 /

+1.2 (+16.02%)

11/16/20 Jefferies
Jefferies downgrades Tilray to Underperform as international markets stall
11/16/20 Jefferies
Tilray downgraded to Underperform from Hold at Jefferies
11/11/20
Fly Intel: Top five analyst downgrades
CURLF Curaleaf
$0.00 /

+ (+0.00%)

11/18/20 Canaccord
Curaleaf price target raised to C$18.50 from C$16 at Canaccord
11/18/20 Alliance Global Partners
Curaleaf price target raised to C$22 from C$16 at Alliance Global Partners
10/29/20 MKM Partners
Curaleaf upgraded to Buy from Neutral at MKM Partners
08/18/20 Canaccord
Curaleaf price target raised to C$16 from C$15 at Canaccord
GM General Motors
$45.02 /

-0.46 (-1.01%)

11/25/20 JPMorgan
Nikola lower as investors focus on 161M share lockup, says JPMorgan
11/25/20 Morgan Stanley
General Motors price target raised to $53 from $44 at Morgan Stanley
11/25/20 Morgan Stanley
Morgan Stanley downgrades Ford to Equal Weight with EV strategy not fully clear
11/20/20 Deutsche Bank
General Motors price target raised to $48 from $43 at Deutsche Bank
TLRY Tilray
$8.69 /

+1.2 (+16.02%)

GM General Motors
$45.02 /

-0.46 (-1.01%)

CURLF Curaleaf
$0.00 /

+ (+0.00%)

CGC Canopy Growth
$28.98 /

+2.13 (+7.93%)

ACB Aurora Cannabis
$10.63 /

+1.92 (+22.04%)

  • 11
    Nov
GM General Motors
$45.02 /

-0.46 (-1.01%)

CGC Canopy Growth
$28.98 /

+2.13 (+7.93%)

GM General Motors
$45.02 /

-0.46 (-1.01%)

CGC Canopy Growth
$28.98 /

+2.13 (+7.93%)

ACB Aurora Cannabis
$10.63 /

+1.92 (+22.04%)

TLRY Tilray
$8.69 /

+1.2 (+16.02%)

GM General Motors
$45.02 /

-0.46 (-1.01%)

CGC Canopy Growth
$28.98 /

+2.13 (+7.93%)

ACB Aurora Cannabis
$10.63 /

+1.92 (+22.04%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.